India GLP-1 Receptor Agonist Market Analysis The India GLP-1 receptor agonist market was valued at USD 1.20 billion in 2025, fueled by expanding contract peptide manufacturing ecosystem, increasing participation of domestic pharmaceutical companies in GLP-1 biosimilar and novel peptide development, and rising availability of specialized diabetes clinics in urban centers
In general, most uncomplicated lower tract infections will be eliminated completely by seven to 10 days of treatment
A number of studies have confirmed the effectiveness of Semaglutide and Tirzepatide for weight loss
Although common, active breakouts and the scars they leave can, for many, lead to self-consciousness and low self-esteem
Your immune system is broken up into two parts: the innate immune system and the adaptive immune system
In the skin, AHR activation elicits diverse responses: in keratinocytes of AD patients, it upregulates filaggrin and loricrin to improve the skin barrier